Ondansetron in the Prevention of Hypotension in Patients Undergoing Spinal Anesthesia

Summary

Ondansetron, a potent 5-HT 3 receptor antagonist commonly used as an antiemetic. The main objective of the present study is to verify the hypothesis that blocking type 3 serotonin receptors with intravenous ondansetron reduces the incidence of spinal anesthesia-induced hypotension

Timeline

Start

2019-03-01

Primary completion

2020-03

Completion

2020-03

Drugs

Indications